Literature DB >> 19332463

Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study.

Paul A Bottomley1, Katherine C Wu, Gary Gerstenblith, Steven P Schulman, Angela Steinberg, Robert G Weiss.   

Abstract

BACKGROUND: Energy metabolism is essential for myocellular viability. The high-energy phosphates adenosine triphosphate (ATP) and phosphocreatine (PCr) are reduced in human myocardial infarction (MI), reflecting myocyte loss and/or decreased intracellular ATP generation by creatine kinase (CK), the prime energy reserve of the heart. The pseudo-first-order CK rate constant, k, measures intracellular CK reaction kinetics and is independent of myocyte number within sampled tissue. CK flux is defined as the product of [PCr] and k. CK flux and k have never been measured in human MI. METHODS AND
RESULTS: Myocardial CK metabolite concentrations, k, and CK flux were measured noninvasively in 15 patients 7 weeks to 16 years after anterior MI using phosphorus magnetic resonance spectroscopy. In patients, mean myocardial [ATP] and [PCr] were 39% to 44% lower than in 15 control subjects (PCr=5.4+/-1.2 versus 9.6+/-1.1 micromol/g wet weight in MI versus control subjects, respectively, P<0.001; ATP=3.4+/-1.1 versus 5.5+/-1.3 micromol/g wet weight, P<0.001). The myocardial CK rate constant, k, was normal in MI subjects (0.31+/-0.08 s(-1)) compared with control subjects (0.33+/-0.07 s(-1)), as was PCr/ATP (1.74+/-0.27 in MI versus 1.87+/-0.45). However, CK flux was halved in MI [to 1.7+/-0.5 versus 3.3+/-0.8 micromol(g . s)(-1); P<0.001].
CONCLUSIONS: These first observations of CK kinetics in prior human MI demonstrate that CK ATP supply is significantly reduced as a result of substrate depletion, likely attributable to myocyte loss. That k and PCr/ATP are unchanged in MI is consistent with the preservation of intracellular CK metabolism in surviving myocytes. Importantly, the results support therapies that primarily ameliorate the effects of tissue and substrate loss after MI and those that reduce energy demand rather than those that increase energy transfer or workload in surviving tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332463      PMCID: PMC2743337          DOI: 10.1161/CIRCULATIONAHA.108.823187

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.

Authors:  P A Bottomley; R G Weiss
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy.

Authors:  P A Bottomley; R J Herfkens; L S Smith; T M Bashore
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

3.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

Authors:  M A Conway; J Allis; R Ouwerkerk; T Niioka; B Rajagopalan; G K Radda
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

4.  Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance.

Authors:  P A Bottomley; C J Hardy; P B Roemer
Journal:  Magn Reson Med       Date:  1990-06       Impact factor: 4.668

5.  The creatine kinase system in normal and diseased human myocardium.

Authors:  J S Ingwall; M F Kramer; M A Fifer; B H Lorell; R Shemin; W Grossman; P D Allen
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

6.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.

Authors:  C J Hardy; R G Weiss; P A Bottomley; G Gerstenblith
Journal:  Am Heart J       Date:  1991-09       Impact factor: 4.749

7.  Adenosine triphosphate compartmentation in living hearts: a phosphorus nuclear magnetic resonance saturation transfer study.

Authors:  R L Nunnally; D P Hollis
Journal:  Biochemistry       Date:  1979-08-07       Impact factor: 3.162

8.  Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy.

Authors:  J L Swain; R L Sabina; R B Peyton; R N Jones; A S Wechsler; E W Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31P-NMR magnetization transfer study of the isolated ferret heart.

Authors:  S Neubauer; B L Hamman; S B Perry; J A Bittl; J S Ingwall
Journal:  Circ Res       Date:  1988-07       Impact factor: 17.367

10.  Kinetics of creatine kinase in heart: a 31P NMR saturation- and inversion-transfer study.

Authors:  H Degani; M Laughlin; S Campbell; R G Shulman
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

View more
  31 in total

Review 1.  CMR for characterization of the myocardium in acute coronary syndromes.

Authors:  Erica Dall'Armellina; Theodoros D Karamitsos; Stefan Neubauer; Robin P Choudhury
Journal:  Nat Rev Cardiol       Date:  2010-09-21       Impact factor: 32.419

2.  Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts.

Authors:  Glenn A Hirsch; Paul A Bottomley; Gary Gerstenblith; Robert G Weiss
Journal:  J Am Coll Cardiol       Date:  2012-02-28       Impact factor: 24.094

3.  Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death.

Authors:  Paul A Bottomley; Gurusher S Panjrath; Shenghan Lai; Glenn A Hirsch; Katherine Wu; Samer S Najjar; Angela Steinberg; Gary Gerstenblith; Robert G Weiss
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

4.  Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency.

Authors:  Petras P Dzeja; Kirsten Hoyer; Rong Tian; Song Zhang; Emirhan Nemutlu; Matthias Spindler; Joanne S Ingwall
Journal:  J Physiol       Date:  2011-08-30       Impact factor: 5.182

Review 5.  The PGC-1 cascade as a therapeutic target for heart failure.

Authors:  Joel Schilling; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2010-10-01       Impact factor: 5.000

6.  Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding.

Authors:  Jessica M Berthiaume; Martin E Young; Xiaoqin Chen; Tracy A McElfresh; Xin Yu; Margaret P Chandler
Journal:  J Mol Cell Cardiol       Date:  2012-04-20       Impact factor: 5.000

7.  CEST MRI reveals a correlation between visceral fat mass and reduced myocardial creatine in obese individuals despite preserved ventricular structure and function.

Authors:  Wissam AlGhuraibawi; Tori Stromp; Rebecca Holtkamp; Bonnie Lam; Wolfgang Rehwald; Steve W Leung; Moriel Vandsburger
Journal:  NMR Biomed       Date:  2019-05-15       Impact factor: 4.044

8.  Transgenic overexpression of ribonucleotide reductase improves cardiac performance.

Authors:  Sarah G Nowakowski; Stephen C Kolwicz; Frederick Steven Korte; Zhaoxiong Luo; Jacqueline N Robinson-Hamm; Jennifer L Page; Frank Brozovich; Robert S Weiss; Rong Tian; Charles E Murry; Michael Regnier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 9.  Quantitative cardiovascular magnetic resonance for molecular imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-03       Impact factor: 5.364

10.  Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections.

Authors:  Abdel-Monem M El-Sharkawy; Refaat E Gabr; Michael Schär; Robert G Weiss; Paul A Bottomley
Journal:  NMR Biomed       Date:  2013-06-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.